Equipment House’s net profit surges to SAR 40.2M in 2023; Q4 at SAR 13.7M

Equipment House’s net profit surges to SAR 40.2M in 2023; Q4 at SAR 13.7M

25/03/2024 Argaam Exclusive

View other reports

Scientific and Medical Equipment House Co. (Equipment House) reported a net profit of SAR 40.2 million (excluding minority interest) for 2023, compared to SAR 17.6 million a year earlier.



Financials (M)

Item 2022 2023 Change‬
Revenues 713.82 799.28 12.0 %
Gross Income 154.85 133.05 (14.1 %)
Operating Income 37.51 68.65 83.0 %
Net Income 17.57 40.06 128.0 %
Average Shares 30.00 30.00 -
EPS (Riyals) 0.59 1.34 128.0 %

This was backed by the revaluation of provisions for expected credit losses for 2023 to stand at SAR 21.5 million. In addition, revenues jumped by 11.97% year-on-year (YoY) to SAR 85.5 million for the same year on new project launches and increased operating sales.

 

The annual profit growth came despite higher Zakat provisions, depreciation and amortization expenses, and financing costs due to the global increase in lending costs.

 

In Q4 2023, Equipment House turned to a net profit of SAR 13.7 million, versus a net loss of SAR 25.31 million in Q4 2022.

 

On a quarterly basis, net profit dropped 22.3% from SAR 17.67 million in Q3 2023.



Current Quarter Comparison (M)

Compared With The
Item Q4 2022 Q4 2023 Change‬
Revenues 188.89 231.78 22.7 %
Gross Income 34.08 35.31 3.6 %
Operating Income (22.44) 23.14 203.1 %
Net Income (25.31) 13.59 153.7 %
Average Shares 30.00 30.00 -
EPS (Riyals) (0.84) 0.45 153.7 %

Total shareholders’ equity, after minority interest, soared to SAR 510 million by Dec. 31, 2023, compared to SAR 470 million in the year before.



Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2014 - - - - - - -
Q2 2014 - - - - - - -
Q3 2014 - - - - - - -
Q4 2014 - - - - - - -
Q1 2015 - - - - - - -
Q2 2015 - - - - - - -
Q3 2015 - - - - - - -
Q4 2015 - - - - - - -
Q1 2016 - - - - - - -
Q2 2016 - - - - - - -
Q3 2016 - - - - - - -
Q4 2016 - - - - - - -
Q1 2017 - - - - - - -
Q2 2017 - - - - - - -
Q3 2017 - - - - - - -
Q4 2017 - - - - - - -
Q1 2018 - - - - - - -
Q2 2018 - - - - - - -
Q3 2018 - - - - - - -
Q4 2018 - - - - - - -
Q1 2019 - - - - - - -
Q2 2019 - - - - - - -
Q3 2019 - - - - - - -
Q4 2019 - - - - - - -
Q1 2020 - - - - - - -
Q2 2020 - - - - - - -
Q3 2020 - - - - - - -
Q4 2020 - - - - - - -
Q1 2021 151.56 - 32.66 - 19.19 - 0.64
Q2 2021 166.08 - 43.72 - 23.92 - 0.80
Q3 2021 176.51 - 37.54 - 16.97 - 0.57
Q4 2021 205.30 - 39.07 - 17.45 - 0.58
Q1 2022 162.56 7.3 % 37.92 16.1 % 16.73 (12.8 %) 0.56
Q2 2022 176.30 6.1 % 46.82 7.1 % 17.36 (27.4 %) 0.58
Q3 2022 186.07 5.4 % 36.03 (4.0 %) 8.79 (48.2 %) 0.29
Q4 2022 188.89 (8.0 %) 34.08 (12.8 %) (25.31) (245.0 %) (0.84)
Q1 2023 164.94 1.5 % 30.88 (18.6 %) 6.86 (59.0 %) 0.23
Q2 2023 190.78 8.2 % 29.89 (36.2 %) 1.94 (88.8 %) 0.06
Q3 2023 211.79 13.8 % 36.97 2.6 % 17.67 101.1 % 0.59
Q4 2023 231.78 22.7 % 35.31 3.6 % 13.59 153.7 % 0.45
2023 799.28 12.0 % 133.05 (14.1 %) 40.06 128.0 % 1.34

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 21.87 % 13.81 % 10.55 %
Q1 2022 22.27 % 14.03 % 10.57 %
Q2 2022 22.39 % 13.20 % 9.51 %
Q3 2022 21.89 % 12.78 % 8.26 %
Q4 2022 21.69 % 7.64 % 2.46 %
Q1 2023 20.64 % 6.45 % 1.08 %
Q2 2023 17.91 % 4.70 % (1.06 %)
Q3 2023 17.43 % 5.98 % 0.15 %
Q4 2023 16.65 % 11.33 % 5.01 %
2023 16.65 % 11.33 % 5.01 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2014 - - - -
Q2 2014 - - - -
Q3 2014 - - - -
Q4 2014 - - - -
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 - - - -
Q2 2020 - - - -
Q3 2020 - - - -
Q4 2020 - - - -
Q1 2021 30.00 - - -
Q2 2021 30.00 - - 14.70
Q3 2021 30.00 - - -
Q4 2021 30.00 2.58 2.46 15.78
Q1 2022 30.00 2.50 2.50 16.34
Q2 2022 30.00 2.28 2.28 16.25
Q3 2022 30.00 2.01 2.01 16.54
Q4 2022 30.00 0.59 0.59 15.68
Q1 2023 30.00 0.26 0.26 15.91
Q2 2023 30.00 (0.26) (0.26) 15.97
Q3 2023 30.00 0.04 0.04 16.56
Q4 2023 30.00 1.34 1.34 17.03

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 21.32 21.32 3.27
Q2 2022 18.98 18.98 2.67
Q3 2022 21.69 21.69 2.64
Q4 2022 69.58 69.58 2.60
Q1 2023 More than 100 More than 100 2.93
Q2 2023 NEG NEG 3.24
Q3 2023 More than 100 More than 100 2.79
Q4 2023 35.76 35.76 2.80

Business Segments (Million)

Compared With The
Period Operation and maintenance Sales of medical devices and revenue from after-sales maintenance services Construction Medications and Medical Supplies Meat and Food Eliminations
Q1 2021 123.04 8.50 10.54 7.37 2.34 (0.22)
Q2 2021 137.92 8.50 10.44 8.00 2.87 (1.64)
Q3 2021 145.75 12.85 8.66 5.88 4.01 (0.65)
Q4 2021 164.19 33.17 20.44 (4.60) 1.30 (9.20)
Q1 2022 130.15 11.47 11.04 8.94 3.48 (2.51)
Q3 2022 144.11 11.32 15.37 14.70 1.19 (0.62)
Q4 2022 142.97 27.07 26.12 (5.58) 0.97 (2.66)
Q1 2023 132.79 14.34 10.87 9.24 1.86 (4.17)
Q2 2023 156.37 15.33 8.78 10.49 1.83 (2.01)
Q3 2023 184.52 13.05 9.54 5.36 1.75 (2.43)
Q4 2023 188.81 28.59 15.81 3.38 2.67 (7.49)

Analysts Estimates (Million)

Item Q4 2023 (e) Q4 2023 (a) Change‬
Average 14.00 13.59 (2.9 %)

Estimates vs Actual (Million)

Item Q4 2023 (e) Q4 2023 (a) Change
Al Rajhi Capital 14.00 13.59 (2.9) %

Current
Market Cap (M Riyal) 1,527.00
Enterprise Value (EV) (M) 1,748.95
Shares Outstanding ((M)) 30.00
EPS ( Riyal) (TTM) 1.40
Book Value (BV) ( Riyal) 17.32
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) More than 100
P/E (TTM) 36.39
Price/book 2.94
Return on Average Assets (%) (TTM) 4.0
Return on Average Equity (%) (TTM) 8.4

Share Price

Scientific and Medical Equipment House Co. (EQUIPMENT HOUSE)


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.